Smart Life Sciences Manufacturing
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Smart Life Sciences Manufacturing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of smart life sciences manufacturing has experienced fast growth in the previous years. It projected an rise from $25.07 billion in 2024 to $28.76 billion in 2025, producing a compound annual growth rate (CAGR) of 14.7%. The surge during the historical period can be credited to factors like optimization of the supply chain, heightened remote monitoring, rising demand for precision medicine, and an increase in healthcare spending.
Smart Life Sciences Manufacturing Market Size Forecast: What’s the Projected Valuation by 2029?
In the years ahead, a swift expansion is projected for the smart life sciences manufacturing market, which is anticipated to reach a value of $50.92 billion in 2029, growing at a compound annual growth rate (CAGR) of 15.4%. The advancement in materials development, the requirement for flexible and wearable electronics, efficiency in energy usage, and a rising demand for IoT devices contribute to the projected growth within the forecast period. The forecast period will also witness predominantly trending technologies such as artificial intelligence (AI), machine learning (ML), RFID and sensor technologies, photovoltaic applications, and display technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/smart-life-sciences-manufacturing-global-market-report
What Are the Drivers Transforming the Smart Life Sciences Manufacturing Market?
The smart life sciences manufacturing market is anticipated to expand with the growing embrace of automation. Automation, which develops software and systems to take over repeatable tasks and limit the need for manual work, has a notable influence on smart life sciences manufacturing. It enhances efficiency, quality, and safety in the creation of pharmaceuticals, biotech products, medical devices, and other associated goods. For example, the International Federation of Robotics, a non-profit organization in Germany, reported in February 2022 that industries around the globe are currently utilizing 3 million industrial robots. This is a 10% rise from 2021. Consequently, the growth of industrial automation is pushing the expansion of the smart life sciences manufacturing market. The smart life sciences manufacturing market is also projected to prosper due to the escalating demand for personalized medicine. Personalized medicine, an approach to medical care that customizes medical verdicts, practices, interventions, and therapies for every patient, is seeing an increased demand. This surge is encouraging the life sciences sector to bring in smart manufacturing technologies and methods for the efficient, accurate, and flexible manufacturing of personalized pharmaceuticals and therapies, thereby enhancing treatment results. For instance, the Personalized Medicine Coalition, a U.S.-based non-profit organization, announced in February 2024 that the FDA had given approval to 16 novel personalized treatments for patients with rare diseases in 2023, an increase from only six in 2022. These newly approved personalized treatments for 2023 included seven cancer drugs and three for other illnesses and conditions. Hence, the burgeoning demand for personalized medicine is promoting the growth of the smart life sciences manufacturing market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12970&type=smp
What Long-Term Trends Will Define the Future of the Smart Life Sciences Manufacturing Market?
Key market leaders are focusing their strategies on the development of innovative AI-based medical technologies to maintain their market dominance. The need for AI-influenced developments in smart life science is crucial for analyzing and deciphering large volumes of data, improving processes, and facilitating personalized interaction. For example, Google Cloud Platform LLC, an American tech company, unveiled two new AI-driven solutions to expedite drug development and precision medicine in May 2023. This inventive tool has the capability to assist scientists in discovering new drugs in a faster, more efficient manner. Also, these tools can enhance the precision of drug creation and decrease the expenses associated with introducing new drugs to the market. Furthermore, this approach has the ability to speed up the production of new drugs and enhance the quality of patients’ lives.
Which Segments in the Smart Life Sciences Manufacturing Market Offer the Most Profit Potential?
The smart life sciences manufacturing market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Augmented Reality And Virtual Reality Systems, Internet of Things (IoT), Artificial Intelligence, Cybersecurity, Big Data, Other Technologies
3) By Application: Pharma, Bio-Pharma, Medical Device
Subsegments:
1) By Solution: Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Automation and Control, Data Analytics And Reporting, Digital Twin Technology, Supply Chain Management
2) By Services: Consulting Services, Integration And Implementation, Maintenance and Support, Training And Education, Managed Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12970&type=smp
Which Firms Dominate the Smart Life Sciences Manufacturing Market by Market Share and Revenue in 2025?
Major companies operating in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric Co., F. Hoffmann-La Roche AG, International Business Machines Corporation, AbbVie Inc., Merck and Co. Inc., Novartis AG, Sophos Group PLC, Bristol Myers Squibb, Thermo Fisher Scientific Inc., GlaxoSmithKline PLC, Sanofi S.A., AstraZeneca PLC, Honeywell International Inc., ABB Ltd., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Emerson Electric Co., Moderna Inc., Regeneron Pharmaceuticals, Biogen Inc., Vertex Pharmaceuticals, Rockwell Automation Inc., Bosch Rexroth AG, Alexion Pharmaceuticals, Fortinet Inc., Genentech Inc.
Which Regions Offer the Highest Growth Potential in the Smart Life Sciences Manufacturing Market?
North America was the largest region in the smart life sciences manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smart life sciences manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12970
“This Report Supports:
1.Business Leaders & Investors – To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers – To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators – To track industry developments and align regulatory frameworks.
4.Consultants & Analysts – To support market entry, expansion strategies, and client advisory work.”
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
